Table 4

Proposed indicators for primary care implementation

Overarching themeProposal for primary care implementation
Holistic Assessment: Pain% patients with a working diagnosis of OA with evidence of pain assessment within the previous 12 months
Holistic Assessment: Function% patients with a working diagnosis of OA with evidence of function assessment within the previous 12 months
Education% patients with a working diagnosis of OA with evidence of education or advice since diagnosis
Exercise 1% patients with a working diagnosis of OA in the hip or knee with evidence of exercise advice or physiotherapy referral since diagnosis
Exercise 2% patients with a working diagnosis of OA with evidence of an activity review within the previous 12 months
Weight loss 1% patients with a BMI ≥30 kg/m2 who have a record of weight loss advice within the previous 12 months
Weight loss 2% patients with a working diagnosis of OA with a BMI ≥25 kg/m2 who have a record of weight loss advice within the previous 12 months
Aids and devices 1% patients with a working diagnosis of OA with evidence of functional impairment who are recorded as receiving a referral or assessment for ambulatory assistive devices within the previous 12 months
Aids and devices 2% patients with a working diagnosis of OA with evidence of functional impairment who are recorded as receiving a referral or assessment for assistive devices within the previous 12 months
Paracetamol 1% patients with a working diagnosis of OA with evidence of paracetamol as the first oral analgesic prescribed or advised since diagnosis
Paracetamol 2% patients with a working diagnosis of OA taking oral analgesics or NSAIDs with evidence that a suitable maximal dose of paracetamol was tried beforehand
Oral NSAIDs 1% patients with a working diagnosis of OA with evidence of a standard NSAID or COX-2 inhibitor as the first oral NSAID prescribed or advised since diagnosis
Oral NSAIDs 2% patients with a working diagnosis of OA taking an oral NSAID with a documented risk assessment prior to first prescription
Gastroprotection% patients with a working diagnosis of OA taking an oral NSAID who are also prescribed a PPI or alternative gastroprotective agent
Specialist assessment% patients with a record of achievement of all other applicable indicators prior to specialist referral*
  • *That is, the other 14 indicators above, depending on applicability of weight and therapy indicators to individual patients.

  • BMI, body mass index; COX, cyclooxygenase; NSAIDs, non-steroidal anti-inflammatories; OA, Osteoarthritis; PPI, proton-pump inhibitor.